HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M400289-JLR200v1 45/12/2339    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raman, A. Articles by Schoeller, D. A. Search for Related Content PubMed PubMed Citation Articles by Raman, A. Articles by Schoeller, D. A. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 45, 2339-2344, December 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology

Validation of deuterium-labeled fatty acids for the measurement of dietary fat oxidation during physical activity

Aarthi Raman^*, Stephane Blanc, Alexandra Adams and Dale A. Schoeller^1,*

^* Interdepartmental Program in Nutritional Sciences, University of Wisconsin-Madison, Madison, WI
d'Ecologie et Physiologie, Strasbourg, France
Department of Family Medicine, University of Wisconsin-Madison, Madison, WI

¹ To whom correspondence should be addressed. e-mail: dschoell{at}nutrisci.wisc.edu

Measurement of ¹³C-labeled fatty acid oxidation is hindered by the need for acetate correction, measurement of the rate of CO₂ production in a controlled environment, and frequent collection of breath samples. The use of deuterium-labeled fatty acids may overcome these limitations. Herein, d₃₁-palmitate was validated against [1-¹³C]palmitate during exercise. Thirteen subjects with body mass index of 22.9 ± 3 kg/m² and body fat of 19.6 ± 11% were subjected to 2 or 4 h of exercise at 25% maximum volume oxygen consumption (VO_2max). The d₃₁-palmitate and [1-¹³C] palmitate were given orally in a liquid meal at breakfast. The d₃-acetate and [1-¹³C]acetate were given during another visit for acetate sequestration correction. Recovery of d₃₁-palmitate in urine at 9 h after dose was compared with [1-¹³C] palmitate recovery in breath. Cumulative recovery of d₃₁-palmitate was 10.6 ± 3% and that of [1-¹³C]palmitate was 5.6 ± 2%. The d₃-acetate and [1-¹³C]acetate recoveries were 85 ± 4% and 54 ± 4%, respectively. When [1-¹³C]acetate recovery was used to correct ¹³C data, the average recovery differences were 0.4 ± 3%. Uncorrected d₃₁-palmitate and acetate-corrected [1-¹³C]palmitate were well correlated (y = 0.96x + 0; P < 0.0001) when used to measure fatty acid oxidation during exercise.

Thus, d₃₁-palmitate can be used in outpatient settings as it eliminates the need for acetate correction and frequent sampling.

Supplementary key words substrate utilization • mass spectrometry • stable isotopes

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Bergouignan, D. A. Schoeller, S. Votruba, C. Simon, and S. Blanc The acetate recovery factor to correct tracer-derived dietary fat oxidation in humans Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E645 - E653. [Abstract] [Full Text] [PDF]